N A Muruve1, K M Steinbecker, A M Luger. 1. Division of Urology, School of Medicine, University of Missouri, University Hospital, Columbia 65212, USA.
Abstract
BACKGROUND: Single wedge biopsy of cadaveric kidneys from donors older than 55 is currently the standard method of evaluating their viability for transplantation. The degree of glomerulosclerosis presently determines whether a kidney can be transplanted, but most biopsies sample only the subcapsular region and may not accurately represent the true renal architecture. Our study evaluated the accuracy of transplant suitability determinations based upon the single wedge biopsy of cadaveric kidneys. METHODS: We took kidneys that were refused by UNOS centers on the basis of biopsy results, examined their histology in detail, and reviewed donor medical histories. Sections were taken from the upper, lower, and mid-portion of each kidney and stained with the periodic acid Schiff stain. Percentage and location of glomerulosclerosis and other relevant pathology were then determined in each section. We compared our findings with the results of the original wedge biopsies obtained at the time of procurement. RESULTS: Nine kidneys were obtained and examined. The wedge biopsies at the time of procurement showed glomerulosclerosis ranging from 8 to 36% (median 17%). The multiple kidney sections we analyzed showed fewer sclerosed glomeruli, ranging from 3 to 15% (median 7%, P<0.001), with most of the sclerosed glomeruli identified located in the immediate subcapsular region (P<0.001). CONCLUSIONS: Wedge biopsies of donor kidneys can overestimate the total amount of glomerulosclerosis, apparently because of a predominance of sclerosis in the kidney's subcapsular region, the area predominantly sampled by the usual wedge biopsy. These inappropriately high estimates of glomerulosclerosis can result in refusal of kidneys that might be suitable for transplantation.
BACKGROUND: Single wedge biopsy of cadaveric kidneys from donors older than 55 is currently the standard method of evaluating their viability for transplantation. The degree of glomerulosclerosis presently determines whether a kidney can be transplanted, but most biopsies sample only the subcapsular region and may not accurately represent the true renal architecture. Our study evaluated the accuracy of transplant suitability determinations based upon the single wedge biopsy of cadaveric kidneys. METHODS: We took kidneys that were refused by UNOS centers on the basis of biopsy results, examined their histology in detail, and reviewed donor medical histories. Sections were taken from the upper, lower, and mid-portion of each kidney and stained with the periodic acid Schiff stain. Percentage and location of glomerulosclerosis and other relevant pathology were then determined in each section. We compared our findings with the results of the original wedge biopsies obtained at the time of procurement. RESULTS: Nine kidneys were obtained and examined. The wedge biopsies at the time of procurement showed glomerulosclerosis ranging from 8 to 36% (median 17%). The multiple kidney sections we analyzed showed fewer sclerosed glomeruli, ranging from 3 to 15% (median 7%, P<0.001), with most of the sclerosed glomeruli identified located in the immediate subcapsular region (P<0.001). CONCLUSIONS: Wedge biopsies of donor kidneys can overestimate the total amount of glomerulosclerosis, apparently because of a predominance of sclerosis in the kidney's subcapsular region, the area predominantly sampled by the usual wedge biopsy. These inappropriately high estimates of glomerulosclerosis can result in refusal of kidneys that might be suitable for transplantation.
Authors: Sumit Mohan; Eric Campenot; Mariana C Chiles; Dominick Santoriello; Eric Bland; R John Crew; Paul Rosenstiel; Geoffrey Dube; Ibrahim Batal; Jai Radhakrishnan; P Rodrigo Sandoval; James Guarrera; M Barry Stokes; Vivette D'Agati; David J Cohen; Lloyd E Ratner; Glen Markowitz Journal: J Am Soc Nephrol Date: 2017-07-06 Impact factor: 10.121
Authors: Syed Ali Husain; Mariana C Chiles; Samnang Lee; Stephen O Pastan; Rachel E Patzer; Bekir Tanriover; Lloyd E Ratner; Sumit Mohan Journal: Clin J Am Soc Nephrol Date: 2017-12-07 Impact factor: 8.237
Authors: Bernd Schröppel; Bernd Krüger; Liron Walsh; Melissa Yeung; Shay Harris; Krista Garrison; Jonathan Himmelfarb; Susan M Lerner; Jonathan S Bromberg; Ping L Zhang; Joseph V Bonventre; Zhu Wang; Alton B Farris; Robert B Colvin; Barbara T Murphy; John P Vella Journal: J Am Soc Nephrol Date: 2009-12-17 Impact factor: 10.121
Authors: S Ali Husain; Kristen L King; Ibrahim Batal; Geoffrey K Dube; Isaac E Hall; Corey Brennan; M Barry Stokes; R John Crew; Dustin Carpenter; Hector Alvarado Verduzco; Raphael Rosen; Shana Coley; Eric Campenot; Dominick Santoriello; Adler Perotte; Karthik Natarajan; Vivette D D'Agati; David J Cohen; Lloyd E Ratner; Glen Markowitz; Sumit Mohan Journal: Clin J Am Soc Nephrol Date: 2020-01-23 Impact factor: 8.237
Authors: Dustin Carpenter; S Ali Husain; Corey Brennan; Ibrahim Batal; Isaac E Hall; Dominick Santoriello; Raphael Rosen; R John Crew; Eric Campenot; Geoffrey K Dube; Jai Radhakrishnan; M Barry Stokes; P Rodrigo Sandoval; Vivette D'Agati; David J Cohen; Lloyd E Ratner; Glen Markowitz; Sumit Mohan Journal: Clin J Am Soc Nephrol Date: 2018-10-25 Impact factor: 8.237